ALFACELL CORP

• BLOOMFIELD, NJ How do I update this listing?

Create Email Alert

Alfacell Corp is based out of Bloomfield. Tamir Biotechnology Inc. develops new drugs from amphibian ribonucleases for the treatment of cancer and other pathological conditions. ONCONASE, Alfacell's trademark name for ranpirnase and its flagship product, was undergoing the last stage of clinical testing (Phase III) in late July 2005.Whalewisdom has at least 38 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2018-01-25. The notice included securities offered of Debt,Option, Warrant or Other Right to Acquire Another Security,Other

Contact Info

alfacell corp
225 BELLEVILLE AVE
BLOOMFIELD NJ    07003
Business Phone: 9737488082
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2018-01-25 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Other 1,500,000 808,638 691,362
2016-12-30 D/A BIOTECHNOLOGY Equity,Other 1,722,476 1,722,476 0
2016-05-20 D BIOTECHNOLOGY Equity,Other 1,622,477 1,524,978 97,499
2015-09-10 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Other 800,000 800,000 0
2014-05-19 D/A BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other INDEFINITE 850,312 INDEFINITE
2014-05-07 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security,Other INDEFINITE 750,311 INDEFINITE
2013-10-04 D BIOTECHNOLOGY Equity 600,000 5,000 595,000
2012-12-27 D BIOTECHNOLOGY Equity,Option, Warrant or Other Right to Acquire Another Security 1,000,000 1,000,000 0
2009-11-02 D BIOTECHNOLOGY Debt,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 3,250,000 3,250,000 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CHARLES MUNIZ subscription required
    EXECUTIVE OFFICER DIRECTOR
DAVID SIDRANSKY subscription required
    DIRECTOR
JOHN P. BRANCACCIO subscription required
    DIRECTOR
STEPHEN K. CARTER subscription required
    DIRECTOR
DONALD R. CONKLIN subscription required
    DIRECTOR
PAUL M. WEISS subscription required
    DIRECTOR
KUSLIMA SHOGEN subscription required
    DIRECTOR
DAVID SIDRANDKY subscription required
    DIRECTOR
LAWRENCE A. KENYON subscription required
    EXECUTIVE OFFICER
JAMIE SULLY subscription required
    EXECUTIVE OFFICER DIRECTOR
FRED KNOLL subscription required
    DIRECTOR
PATRICK OSTRONICK subscription required
    DIRECTOR
JOANNE BARSA subscription required
    EXECUTIVE OFFICER
JAMIE SULLEY subscription required
    EXECUTIVE OFFICER DIRECTOR
PATRICK OSTRONIC subscription required
    DIRECTOR

Elevate your investments